Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


15.01.2018

1 Am J Cardiol
1 Am J Epidemiol
1 Am J Kidney Dis
1 Am J Med
1 Am J Nephrol
3 Biochem Biophys Res Commun
2 Circulation
2 Diabet Med
3 Diabetes
5 Diabetes Care
7 Diabetes Obes Metab
3 Diabetologia
2 Eur J Endocrinol
1 J Autoimmun
4 J Clin Endocrinol Metab
1 J Diabetes Complications
1 Metabolism
1 Nat Genet
1 Pediatr Diabetes
3 PLoS One
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. GORTER TM, Streng KW, van Melle JP, Rienstra M, et al
    Diabetes Mellitus and Right Ventricular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Am J Cardiol. 2017 Dec 11. pii: S0002-9149(17)31866.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. HAKOLA L, Takkinen HM, Niinisto S, Ahonen S, et al
    Infant Feeding in Relation to the Risk of Advanced Islet Autoimmunity and Type 1 Diabetes in Children With Increased Genetic Susceptibility: A Cohort Study.
    Am J Epidemiol. 2018;187:34-44.
    PubMed     Text format     Abstract available


    Am J Kidney Dis

  3. KELLER T, Wanner C, Krane V, Kraus D, et al
    Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.
    Am J Kidney Dis. 2018 Jan 5. pii: S0272-6386(17)31074.
    PubMed     Text format     Abstract available


    Am J Med

  4. PACKER M
    Should We be Combining Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors in Treating Diabetes?
    Am J Med. 2018 Jan 5. pii: S0002-9343(17)31296.
    PubMed     Text format    


    Am J Nephrol

  5. TRIEBSWETTER S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, et al
    Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Am J Nephrol. 2018;47:30-39.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. LIU T, Duan W, Nizigiyimana P, Gao L, et al
    Alpha-mangostin attenuates diabetic nephropathy in association with suppression of acid sphingomyelianse and endoplasmic reticulum stress.
    Biochem Biophys Res Commun. 2018 Jan 6. pii: S0006-291X(18)30046.
    PubMed     Text format     Abstract available

  7. GUNDALA NKV, Naidu VGM, Das UN
    Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid.
    Biochem Biophys Res Commun. 2018 Jan 5. pii: S0006-291X(18)30007.
    PubMed     Text format     Abstract available

  8. GONG Y, Zhu Y, Zhu B, Si X, et al
    LncRNA MALAT1 is up-regulated in diabetic gastroparesis and involved in high-glucose-induced cellular processes in human gastric smooth muscle cells.
    Biochem Biophys Res Commun. 2018 Jan 6. pii: S0006-291X(18)30044.
    PubMed     Text format     Abstract available


    Circulation

  9. IANIRO G, Cammarota G, Gasbarrini A
    Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium".
    Circulation. 2018;137:213-214.
    PubMed     Text format    

  10. PLUTZKY J, Bakris G
    Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Diabetes Mellitus and Chronic Kidney Disease: Turning the Page.
    Circulation. 2018;137:130-133.
    PubMed     Text format    


    Diabet Med

  11. LOERBROKS A, Herr RM, Icks A, Bosch JA, et al
    The association of self-reported diabetes with impaired social functioning in low-, middle- and high-income countries: findings from the World Health Survey.
    Diabet Med. 2018 Jan 7. doi: 10.1111/dme.13578.
    PubMed     Text format     Abstract available

  12. PILEMANN-LYBERG S, Persson F, Frystyk J, Rossing P, et al
    The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial.
    Diabet Med. 2018 Jan 7. doi: 10.1111/dme.13577.
    PubMed     Text format     Abstract available


    Diabetes

  13. MISHRA M, Duraisamy AJ, Kowluru RA
    Sirt1- A Guardian of the Development of Diabetic Retinopathy.
    Diabetes. 2018 Jan 8. pii: db17-0996. doi: 10.2337/db17-0996.
    PubMed     Text format     Abstract available

  14. LI J, Huynh P, Dai A, Wu T, et al
    Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1).
    Diabetes. 2018 Jan 8. pii: db17-0134. doi: 10.2337/db17-0134.
    PubMed     Text format     Abstract available

  15. CHEN X, Iriscilla A, Shannon C, Fourcaudot M, et al
    The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.
    Diabetes. 2018 Jan 9. pii: db17-0318. doi: 10.2337/db17-0318.
    PubMed     Text format     Abstract available


    Diabetes Care

  16. KAUL S
    Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821-831.
    Diabetes Care. 2018 Jan 8. pii: dc18-er03a. doi: 10.2337.
    PubMed     Text format    

  17. LOWE WL JR., Bain JR, Nodzenski M, Reisetter AC, et al
    Erratum. Maternal BMI and Glycemia Impact the Fetal Metabolome. Diabetes Care 2017;40:902-910.
    Diabetes Care. 2018 Jan 8. pii: dc18-er03b. doi: 10.2337.
    PubMed     Text format    

  18. STANDL E, Stevens SR, Armstrong PW, Buse JB, et al
    Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
    Diabetes Care. 2018 Jan 8. pii: dc17-1778. doi: 10.2337/dc17-1778.
    PubMed     Text format     Abstract available

  19. CLAESSEN H, Kvitkina T, Narres M, Trautner C, et al
    Markedly Decreasing Incidence of Blindness in People With and People Without Diabetes in Southern Germany.
    Diabetes Care. 2018 Jan 9. pii: dc17-2031. doi: 10.2337/dc17-2031.
    PubMed     Text format     Abstract available

  20. REIS JP, Allen NB, Bancks MP, Carr JJ, et al
    Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study.
    Diabetes Care. 2018 Jan 9. pii: dc17-2233. doi: 10.2337/dc17-2233.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  21. PACKER M
    Have We Really Demonstrated the Cardiovascular Safety of Antihyperglycemic Drugs? Rethinking the Concepts of Macrovascular and Microvascular Disease in Type 2 Diabetes.
    Diabetes Obes Metab. 2018 Jan 5. doi: 10.1111/dom.13207.
    PubMed     Text format     Abstract available

  22. TERAUCHI Y, Tamura M, Senda M, Gunji R, et al
    Long-term safety and efficacy of tofogliflozin add-on to insulin in patients with type 2 diabetes: results from a 52-week, multicenter, randomized, double-blind, open-label extension, Phase 4 study in Japan (J-STEP/INS).
    Diabetes Obes Metab. 2018 Jan 5. doi: 10.1111/dom.13213.
    PubMed     Text format     Abstract available

  23. ILANY J, Bhandari H, Nabriski D, Toledano Y, et al
    Effect of prandial treatment timing adjustment, based on continuous glucose monitoring, in patients with type 2 diabetes uncontrolled on once daily basal insulin: a randomized, phase IV study.
    Diabetes Obes Metab. 2018 Jan 8. doi: 10.1111/dom.13214.
    PubMed     Text format     Abstract available

  24. JABBOUR SA, Frias JP, Guja C, Hardy E, et al
    Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin added to metformin monotherapy on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.
    Diabetes Obes Metab. 2018 Jan 5. doi: 10.1111/dom.13206.
    PubMed     Text format     Abstract available

  25. PORKSEN NK, Linnebjerg H, Lam ECQ, Garhyan P, et al
    Basal Insulin Peglispro Increases Lipid Oxidation, Metabolic Flexibility, Thermogenesis And Ketone Bodies Compared To Insulin Glargine In Subjects With Type 1 Diabetes Mellitus.
    Diabetes Obes Metab. 2018 Jan 8. doi: 10.1111/dom.13215.
    PubMed     Text format     Abstract available

  26. MENEGHINI LF, Lee L, Gupta S, Preblick R, et al
    The association of hypoglycaemia severity and clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin.
    Diabetes Obes Metab. 2018 Jan 5. doi: 10.1111/dom.13208.
    PubMed     Text format     Abstract available

  27. MATHIEU C, Bode BW, Franek E, Philis-Tsimikas A, et al
    Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase 3 trial.
    Diabetes Obes Metab. 2018 Jan 8. doi: 10.1111/dom.13205.
    PubMed     Text format     Abstract available


    Diabetologia

  28. VAN STEEN SC, Woodward M, Chalmers J, Li Q, et al
    Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
    Diabetologia. 2018 Jan 8. pii: 10.1007/s00125-017-4539.
    PubMed     Text format     Abstract available

  29. BERK KA, Buijks HIM, Verhoeven AJM, Mulder MT, et al
    Group cognitive behavioural therapy and weight regain after diet in type 2 diabetes: results from the randomised controlled POWER trial.
    Diabetologia. 2018 Jan 9. pii: 10.1007/s00125-017-4531.
    PubMed     Text format     Abstract available

  30. STEINARSSON AO, Rawshani A, Gudbjornsdottir S, Franzen S, et al
    Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register.
    Diabetologia. 2018 Jan 9. pii: 10.1007/s00125-017-4532.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  31. JENSEN RB, Thankamony A, Holst KK, Janssen JAMJL, et al
    Genetic influence on the associations between IGF-I and glucose metabolism in a cohort of elderly twins.
    Eur J Endocrinol. 2018;178:155-163.
    PubMed     Text format     Abstract available

  32. SCOTT ES, Long GV, Guminski A, Clifton-Bligh RJ, et al
    The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Eur J Endocrinol. 2018;178:175-182.
    PubMed     Text format     Abstract available


    J Autoimmun

  33. SHARMA A, Liu X, Hadley D, Hagopian W, et al
    Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    J Autoimmun. 2018 Jan 5. pii: S0896-8411(17)30739.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  34. DRAZNIN B, Kahn PA, Wagner N, Hirsch IB, et al
    Clinical Diabetes Centers of Excellence - A Model for Future Adult Diabetes Care.
    J Clin Endocrinol Metab. 2018 Jan 4. pii: 4788756. doi: 10.1210/jc.2017-02388.
    PubMed     Text format     Abstract available


  35. CORRIGENDUM FOR "Complement C3 Associates With Incidence of Diabetes, but No Evidence of a Causal Relationship".
    J Clin Endocrinol Metab. 2018 Jan 5. pii: 4791453. doi: 10.1210/jc.2017-02806.
    PubMed     Text format    

  36. VILLARD O, Brun JF, Bories L, Molinari N, et al
    The second phase of insulin secretion in non-diabetic islet-grafted recipients is altered and can predict graft outcome.
    J Clin Endocrinol Metab. 2018 Jan 8. pii: 4792931. doi: 10.1210/jc.2017-01342.
    PubMed     Text format     Abstract available

  37. YU D, Cai Y, Graffy J, Holman D, et al
    Development and external validation of risk scores for cardiovascular hospitalisation and rehospitalisation in diabetes patients.
    J Clin Endocrinol Metab. 2018 Jan 8. pii: 4792932. doi: 10.1210/jc.2017-02293.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  38. DE BLOCK CEM, Shivalkar B, Goovaerts W, Brits T, et al
    Coronary artery calcifications and diastolic dysfunction versus visceral fat area in type 1 diabetes: VISCERA study.
    J Diabetes Complications. 2017 Nov 28. pii: S1056-8727(17)30597.
    PubMed     Text format     Abstract available


    Metabolism

  39. BROSKEY NT, Obanda DN, Burton JH, Cefalu WT, et al
    Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.
    Metabolism. 2018 Jan 4. pii: S0026-0495(17)30359.
    PubMed     Text format     Abstract available


    Nat Genet

  40. GRARUP N, Moltke I, Andersen MK, Dalby M, et al
    Loss-of-function variants in ADCY3 increase risk of obesity and type 2 diabetes.
    Nat Genet. 2018 Jan 8. pii: 10.1038/s41588-017-0022.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  41. HAYNES A, Bulsara MK, Jones TW, Davis EA, et al
    Incidence of childhood onset type 1 diabetes in Western Australia from 1985 to 2016: Evidence for a plateau.
    Pediatr Diabetes. 2018 Jan 4. doi: 10.1111/pedi.12636.
    PubMed     Text format     Abstract available


    PLoS One

  42. OZTURK MC, Xu Q, Cinar A
    Agent-based modeling of the interaction between CD8+ T cells and Beta cells in type 1 diabetes.
    PLoS One. 2018;13:e0190349.
    PubMed     Text format     Abstract available

  43. LEI X, Huang S
    Correction: Enrichment of minor allele of SNPs and genetic prediction of type 2 diabetes risk in British population.
    PLoS One. 2018;13:e0191210.
    PubMed     Text format     Abstract available

  44. ABDULKADER RCRM, Burdmann EA, Lebrao ML, Duarte YAO, et al
    Aging and decreased glomerular filtration rate: An elderly population-based study.
    PLoS One. 2017;12:e0189935.
    PubMed     Text format     Abstract available


    Transplantation

  45. JIN L, Lim SW, Jin J, Luo K, et al
    Effect of Conversion to CTLA4Ig Treatment on Tacrolimus-Induced Diabetic Rats.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002048.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: